These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32255732)

  • 21. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
    Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
    Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CpG island shore methylation regulates caveolin-1 expression in breast cancer.
    Rao X; Evans J; Chae H; Pilrose J; Kim S; Yan P; Huang RL; Lai HC; Lin H; Liu Y; Miller D; Rhee JK; Huang YW; Gu F; Gray JW; Huang TM; Nephew KP
    Oncogene; 2013 Sep; 32(38):4519-28. PubMed ID: 23128390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aerobic exercise training resets the human skeletal muscle methylome 10 years after breast cancer treatment and survival.
    Gorski PP; Raastad T; Ullrich M; Turner DC; Hallén J; Savari SI; Nilsen TS; Sharples AP
    FASEB J; 2023 Jan; 37(1):e22720. PubMed ID: 36542473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer.
    Verschuur-Maes AH; de Bruin PC; van Diest PJ
    Breast Cancer Res Treat; 2012 Dec; 136(3):705-15. PubMed ID: 23104224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
    Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
    Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disentangling tumorigenesis-associated DNA methylation changes in colorectal tissues from those associated with ageing.
    Orjuela S; Parker HR; Sajibu S; Cereatti F; Sauter M; Buffoli F; Robinson MD; Marra G
    Epigenetics; 2022 Jun; 17(6):677-694. PubMed ID: 34369258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypermethylation of a small CpGuanine-rich region correlates with loss of activator protein-2alpha expression during progression of breast cancer.
    Douglas DB; Akiyama Y; Carraway H; Belinsky SA; Esteller M; Gabrielson E; Weitzman S; Williams T; Herman JG; Baylin SB
    Cancer Res; 2004 Mar; 64(5):1611-20. PubMed ID: 14996719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays.
    Yan PS; Chen CM; Shi H; Rahmatpanah F; Wei SH; Caldwell CW; Huang TH
    Cancer Res; 2001 Dec; 61(23):8375-80. PubMed ID: 11731411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal breast tissue DNA methylation differences at regulatory elements are associated with the cancer risk factor age.
    Johnson KC; Houseman EA; King JE; Christensen BC
    Breast Cancer Res; 2017 Jul; 19(1):81. PubMed ID: 28693600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation of progesterone receptor isoform A promoter in normal breast tissue: An epigenetic link between early age at menarche and risk of breast cancer?
    Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Nariman-Saleh-Fam Z; Bastami M; Saadatian Z; Zendehbad Z; Tavakkoly-Bazzaz J
    J Cell Biochem; 2019 Aug; 120(8):12393-12401. PubMed ID: 30816620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of epigenetically regulated genes in breast cancer cell lines.
    Loss LA; Sadanandam A; Durinck S; Nautiyal S; Flaucher D; Carlton VE; Moorhead M; Lu Y; Gray JW; Faham M; Spellman P; Parvin B
    BMC Bioinformatics; 2010 Jun; 11():305. PubMed ID: 20525369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis.
    Fleischer T; Frigessi A; Johnson KC; Edvardsen H; Touleimat N; Klajic J; Riis ML; Haakensen VD; Wärnberg F; Naume B; Helland A; Børresen-Dale AL; Tost J; Christensen BC; Kristensen VN
    Genome Biol; 2014; 15(8):435. PubMed ID: 25146004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation profiling of ductal carcinoma in situ and its relationship to histopathological features.
    Pang JM; Deb S; Takano EA; Byrne DJ; Jene N; Boulghourjian A; Holliday A; Millar E; Lee CS; O'Toole SA; Dobrovic A; Fox SB
    Breast Cancer Res; 2014 Oct; 16(5):423. PubMed ID: 25331261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation profiling of CpG islands in human breast cancer cells.
    Huang TH; Perry MR; Laux DE
    Hum Mol Genet; 1999 Mar; 8(3):459-70. PubMed ID: 9949205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation target array for rapid analysis of CpG island hypermethylation in multiple tissue genomes.
    Chen CM; Chen HL; Hsiau TH; Hsiau AH; Shi H; Brock GJ; Wei SH; Caldwell CW; Yan PS; Huang TH
    Am J Pathol; 2003 Jul; 163(1):37-45. PubMed ID: 12819009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
    Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
    Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyper-methylation of the upstream CpG island shore is a likely mechanism of GPER1 silencing in breast cancer cells.
    Manjegowda MC; Gupta PS; Limaye AM
    Gene; 2017 May; 614():65-73. PubMed ID: 28286086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylome and transcriptome analyses reveal insights into the epigenetic basis for the good survival of hypomethylated ER-positive breast cancer subtype.
    Chen XQ; Zhang F; Su QC; Zeng C; Xiao FH; Peng Y
    Clin Epigenetics; 2020 Jan; 12(1):16. PubMed ID: 31959227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
    Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
    Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA methylation at enhancers identifies distinct breast cancer lineages.
    Fleischer T; Tekpli X; Mathelier A; Wang S; Nebdal D; Dhakal HP; Sahlberg KK; Schlichting E; ; Børresen-Dale AL; Borgen E; Naume B; Eskeland R; Frigessi A; Tost J; Hurtado A; Kristensen VN
    Nat Commun; 2017 Nov; 8(1):1379. PubMed ID: 29123100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.